Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial-Reference-Cited by-同舟云学术

Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial

Published:2019-01-18 Issue:5 Volume:142 Page:1203-1214
ISSN:0006-8950
Container-title:Brain
language:en
Short-container-title:

Author:

Pijpers Judith A¹,Kies Dennis A¹²,Louter Mark A¹³,van Zwet Erik W⁴,Ferrari Michel D¹,Terwindt Gisela M¹

Affiliation:

1. Department of Neurology, Leiden University Medical Centre (LUMC), Leiden, The Netherlands

2. Department of Radiology, Leiden University Medical Centre (LUMC), Leiden, The Netherlands

3. Department of Psychiatry, Leiden University Medical Centre (LUMC), Leiden, The Netherlands

4. Department of Medical Statistics, Leiden University Medical Centre (LUMC), Leiden, The Netherlands

Funder

Netherlands Organization for Scientific Research

NWO

Dutch Brain Foundation

Publisher

Oxford University Press (OUP)

Subject

Neurology (clinical)

Link

http://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awz052/28408522/awz052.pdf

Reference48 articles.

1. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial;Aurora;Cephalalgia,2010

2. Australian Government. Australian Public Assessment Report for Botulinum Toxin Type A Proprietary Product Name: Botox [Internet]. 2011. https://www.tga.gov.au/sites/default/files/auspar-botox.pdf (11 July 2017, date last accessed).

3. Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation;Bendtsen;J Headache Pain,2018

4. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study;Bigal;Lancet Neurol,2015

5. Therapeutic antibodies against CGRP or its receptor;Bigal;Br J Clin Pharmacol,2015

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine;Cephalalgia;2024-09

2. Insights from 25 years of onabotulinumtoxinA in migraine — mechanisms and management;Nature Reviews Neurology;2024-08-19

3. Effectiveness and safety of pharmacological prophylaxis for chronic migraine: a systematic review and network meta-analysis;Journal of Neurology;2024-06-23

4. A Risk-Difference Meta-Analysis for the Prophylactic Treatments of Chronic Migraine;Cureus;2024-06-16

5. The Nursing Role in the Management of Medication Overuse Headache: Realities and Prospects;Brain Sciences;2024-06-14